Table 1

Baseline characteristics

VariablesEndovascular therapy (n=77)Bridging therapy (n=45)P value
Demographics
 Age (years), mean (SD)67.5±7.767.1±7.80.80
 Sex (female), n (%)38 (49.4)18 (40.0)0.32
 BMI (kg/m2), mean (SD)24.3±2.725.1±4.60.23
Risk factors
 Hypertension, n (%)53 (68.8)24 (53.3)0.09
 Diabetes, n (%)16 (20.8)8 (17.8)0.69
 Dyslipidaemia, n (%)3 (3.9)4 (8.9)0.42
 Current smoker, n (%)23 (29.9)8 (17.8)0.14
 Current drinker, n (%)7 (9.1)8 (17.78)0.16
Medical history
 Cerebral infarction, n (%)14 (18.2)8 (17.8)0.96
 Atrial fibrillation, n (%)26 (33.8)10 (22.2)0.17
 Coronary heart disease, n (%)12 (15.6)11 (24.4)0.23
Stroke subtype
 Atherothrombotic, n (%)20 (26.0)10 (22.2)0.85
 Cardioembolic, n (%)44 (57.1)26 (57.8)
 Undetermined or other, n (%)13 (16.9)9 (20.0)
Occlusion site*
 ICA, n (%)29 (37.7)17 (37.8)0.74
 M1 segment, n (%)47 (61.0)28 (62.2)
 M2 segment, n (%)1 (1.3)0 (0)
Interval between stroke onset and arrival
 <4.5 hours, n (%)54 (70.1)32 (71.1)0.91
 4.5–6 hours, n (%)23 (29.9)13 (28.9)
ASPECTS value based on CT, n (%)
 01 (1.3)2 (4.4)0.19
 17 (9.1)2 (4.4)
 22 (2.6)4 (8.9)
 337 (48.1)16 (35.6)
 421 (27.3)11 (24.4)
 59 (11.7)10 (22.2)
NIHSS score at admission, median (IQR)17 (14–20)18 (13–20)0.83
Median infarct core volume, mean (SD)†67.0±40.061.6±37.60.52
  • *M1 segment indicates the middle cerebral artery horizontal or sphenoidal segment; M2 segment indicates the middle cerebral artery insular segment.

  • †The definition of infarct core was an area with an apparent diffusion coefficient ≤620×10−6 mm2/s on MRI or a relative cerebral blood flow below 30% on CT perfusion.

  • ASPECTS, Alberta Stroke Program Early CT Score; BMI, body mass index; ICA, internal carotid artery; NIHSS, National Institutes of Health Stroke Scale.